Open Access
- 1 May 2014
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 174 (5) , 819-821
Abstract
While most headaches are attributable to benign conditions, patients and physicians are often concerned about intracranial pathologic conditions. However, the yield of significant abnormalities on neuroimaging in patients with chronic headaches is 1% to 3%.1-3 Given the comparable yield in patients without headaches, multiple guidelines have recommended against routine headache neuroimaging,4-6 and efforts to improve the efficiency of health care utilization, such as the Choosing Wisely campaign (ABIM [American Board of Internal Medicine] Foundation; http://www.choosingwisely.org), have identified these tests as a target. However, little is known about recent headache neuroimaging utilization, associated expenditures, and temporal trends in the United States.Keywords
This publication has 6 references indexed in Scilit:
- Neurophysiological tests and neuroimaging procedures in non-acute headache (2nd edition)European Journal of Neurology, 2010
- Imaging results in a consecutive series of 530 new patients in the Birmingham Headache ServiceJournal of Neurology, 2010
- Neuroimaging in the Evaluation of Patients with Non-Acute HeadacheCephalalgia, 2005
- Brain MR Imaging in the Evaluation of Chronic Headache in Patients without Other Neurologic SymptomsAcademic Radiology, 2001
- Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED]Neurology, 2000
- Headache. American College of Radiology. ACR Appropriateness Criteria.2000